| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.61 | 0.0003 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.46 | 0.0007 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |